Product Information

LOREEV XR 1.5 MG CAPSULE is a brand product labeled by Almatica Pharma LLC, priced at $14.2182 per EA under NDC 52427066130. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Aug 27, 2021.

The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOREEV XR 1.5 MG CAPSULE

lorazepam
$14.2182per EA
High Outlier
DEA Schedule CIV

Strength

1.5 mg/1

NDC

52427066130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LORAZEPAM

Approval Type

New Drug (NDA)

FDA Application

NDA214826

FDA Approved

8/27/2021

On Market Since

3/1/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for LOREEV XR 1.5 MG CAPSULE has been published 136 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$14.2182 per EA
All-time high$14.3020 (Apr 16, 2025)
All-time low$14.1032 (Apr 17, 2024)
52-week high$14.2630
52-week low$14.2172
Median price$14.2476
Average price$14.2412
Largest weekly change+0.5% (May 22, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+0.0%

1M

-0.2%

3M

-0.2%

6M

-0.2%

1Y

-0.3%

3Y

N/A

5Y

N/A

All

+0.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lorazepam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOREEV XR 1.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LOREEV XR 1.5 MG CAPSULE, manufactured by Almatica Pharma LLC, is $14.2182 per EA (NDC 52427066130), effective Nov 18, 2026.

How has the price of LOREEV XR 1.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LOREEV XR 1.5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for LOREEV XR 1.5 MG CAPSULE?

Since Apr 17, 2024, the NADAC for LOREEV XR 1.5 MG CAPSULE has ranged from a low of $14.1032 (Apr 17, 2024) to a high of $14.3020 (Apr 16, 2025), with a median of $14.2476 per EA.

Are there cheaper alternatives to LOREEV XR 1.5 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of LOREEV XR 1.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LOREEV XR 1.5 MG CAPSULE?

LOREEV XR 1.5 MG CAPSULE (NDC 52427066130) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.